首页> 美国卫生研究院文献>Toxicological Research >Subchronic Oral Dose Toxicity Study of Enterococcus Faecalis 2001 (EF 2001) in Mice
【2h】

Subchronic Oral Dose Toxicity Study of Enterococcus Faecalis 2001 (EF 2001) in Mice

机译:粪肠球菌2001(EF 2001)对小鼠的亚慢性口服毒性研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

As a part of general toxicity studies of Enterococcus Faecalis 2001 (EF 2001) prepared using heat-treatment bacillus mort body EF 2001 in mice, this study examined the toxicity of EF 2001 in single and repeated administrations following the previous report in order to apply this product to preventive medicine. The safety of oral ingestion of EF 2001 was examined in 6-week-old male and female ICR mice with 1,000 mg/kg, 3,000 mg/kg and 5,000 mg/kg body weight/day administrated by gavage of the maximum acceptable dose of EF 2001. The study was conducted using distilled water as a control following the methods for general toxicity studies described in the “Guidelines for Non-clinical Studies of Pharmaceutical Products 2002”. As a control, 1) observation of general conditions, 2) measurement of body weight, 3) determination of food consumption, 4) determination of water consumption, 5) blood test and urinalysis and 6) pathological examination were performed for the administration of EF 2001. Mice received EF 2001 for 13 weeks and results were compared with those of the control group that received distilled water. The results of the above examinations revealed no significant differences between control and EF 2001 groups for both males and females. Thus, no notable toxicity was confirmed with single and repeated oral administrations of EF 2001. Oral administration in the above doses did not result in abnormal symptoms or death during the observation period. No abnormalities in blood cell count or organ weights were seen. Without any evidence of toxicity to cells and organs, EF 2001 is speculated to not adversely affect living organisms. The 50% lethal dose of EF 2001 with oral administration in mice is estimated to be greater than 5,000 mg/kg body weight/day for both male and female mice. Therefore, LD50 value for animals was 5,000 mg/kg or more.
机译:作为粪便肠球菌2001(EF 2001)的一般毒性研究的一部分,该研究使用热处理的人体死后芽孢杆菌EF 2001对小鼠进行了研究,该研究按照先前的报告对单次和重复施用EF 2001的毒性进行了研究,以便应用产品用于预防医学。在6周大的雄性和雌性ICR小鼠中,口服饲喂EF 2001的安全性进行了研究,体重分别为1,000 mg / kg,3,000 mg / kg和5,000 mg / kg体重/天,通过管饲EF最大可接受剂量2001年。按照“药物非临床研究指南2002”中所述的一般毒性研究方法,使用蒸馏水作为对照进行研究。作为对照,对EF的施用进行了1)观察一般情况,2)体重测量,3)食物消耗的确定,4)水消耗的确定,5)血液检查和尿液分析以及6)病理检查。 2001年。小鼠接受EF 2001干预13周,并将结果与​​接受蒸馏水的对照组进行比较。上述检查的结果表明,对照组和EF 2001组在男性和女性之间均无显着差异。因此,单次或多次口服EF 2001并没有发现明显的毒性。在观察期内,以上述剂量口服不会导致异常症状或死亡。血细胞计数或器官重量未见异常。由于没有任何对细胞和器官有毒性的证据,EF 2001被认为不会对活生物体产生不利影响。雄性和雌性小鼠口服施用的EF 2001的50%致死剂量估计都超过5,000 mg / kg体重/天。因此,动物的LD50值为5,000 mg / kg或更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号